| Supplementary Protection Certificate (SPC) Summary | |||||||||||
| SPC No. | 2012/007 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Date of filing | 14/02/2012 | ||||||||||
| Notification of Application Published | 14/03/2012 | ||||||||||
| Status | Granted | ||||||||||
| Notification of Grant Published | 28/08/2013 | ||||||||||
| Date of Expiry of SPC | 17/11/2026 | ||||||||||
| Applicant |
THE SCRIPPS RESEARCH INSTITUTE 10550 North Torrey Pines Road La Jolla, California 92037 UNITED STATES OF AMERICA |
||||||||||
| Patent Number | 1587821 | ||||||||||
| Title of Invention | COMPOSITIONS AND METHODS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING | ||||||||||
| Date of Expiry of Patent | 18/12/2023 | ||||||||||
| Product Type | Medicinal Product | ||||||||||
| Product Identity | Vyndaqel- Tafamidis meglumine | ||||||||||
| Market Authorisation | Ireland | ||||||||||
| Authorisation No | EU/1/11/717/001 | ||||||||||
| Authorisation Date | 16/11/2011 | ||||||||||
| Identity of Product Authorised | Vyndaqel - Tafamidis | ||||||||||
| Address for Service |
TOMKINS & CO. 5 Dartmouth Road Dublin 6 IRELAND |
||||||||||
| Renewal Fees |
|
||||||||||
| 07/11/2016 | The expiry date of SPC No. 2012/007 has been amended to bring it into line with the decision from the Court of Justice of the European Union in Case C-471/14. New expiry date is 17/11/2026. | ||||||||||
| 22/04/2026 | Notification of a waiver received on 16 April 2026 in accordance with Article 5(2)(b) and (c) of Regulation (EC) No 469/2009 (as amended by Regulation (EU) 2019/933) concerning the Irish Supplementary Protection Certificate 2012/007. | ||||||||||